Oral Oncology

Oral Oncology

口腔肿瘤学

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Oral Oncology》是由Elsevier Ltd出版社于1997年创办的英文国际期刊(ISSN: 1368-8375,E-ISSN: 1879-0593),该期刊长期致力于牙科与口腔外科领域的创新研究,主要研究方向为医学-牙科与口腔外科。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0818...%),以发表牙科与口腔外科领域等方向的原创性研究为核心(研究类文章占比84.18%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在158篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Oral Oncology审稿周期约为 约3月 。该刊近年未被列入国际预警名单,年发文量约158篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 158 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科 ONCOLOGY 肿瘤学
2区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科 ONCOLOGY 肿瘤学
1区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:DENTISTRY, ORAL SURGERY & MEDICINE SCIE Q1 13 / 157

92%

学科:ONCOLOGY SCIE Q2 95 / 322

70.7%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:DENTISTRY, ORAL SURGERY & MEDICINE SCIE Q1 30 / 157

81.21%

学科:ONCOLOGY SCIE Q1 62 / 322

80.9%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:8.7 SJR:1.257 SNIP:1.379
学科类别 分区 排名 百分位
大类:Dentistry 小类:Oral Surgery Q1 1 / 74

99%

大类:Dentistry 小类:Oncology Q1 71 / 404

82%

大类:Dentistry 小类:Cancer Research Q2 66 / 230

71%

期刊发文

  • Improved accuracy of auto-segmentation of organs at risk in radiotherapy planning for nasopharyngeal carcinoma based on fully convolutional neural network deep learning

    Author: Peng, Yinglin; Liu, Yimei; Shen, Guanzhu; Chen, Zijie; Chen, Meining; Miao, Jingjing; Zhao, Chong; Deng, Jincheng; Qi, Zhenyu; Deng, Xiaowu

    Journal: ORAL ONCOLOGY. 2023; Vol. 136, Issue , pp. -. DOI: 10.1016/j.oraloncology.2022.106261

  • MALT lymphoma of the head and neck: Surgery alone can be an option

    Author: Fu, Rao; Wen, Xutao; Li, Zhengrui; Zhang, Ling

    Journal: ORAL ONCOLOGY. 2023; Vol. 136, Issue , pp. -. DOI: 10.1016/j.oraloncology.2022.106258

  • Explainable ensemble learning model improves identification of candidates for oral cancer screening

    Author: Adeoye, John; Zheng, Li-Wu; Thomson, Peter; Choi, Siu-Wai; Su, Yu-Xiong

    Journal: ORAL ONCOLOGY. 2023; Vol. 136, Issue , pp. -. DOI: 10.1016/j.oraloncology.2022.106278

  • CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer

    Author: Xiao, Yao; Mao, Liang; Yang, Qi-Chao; Wang, Shuo; Wu, Zhi-Zhong; Wan, Shu-Cheng; Zhang, Meng-Jie; Sun, Zhi-Jun

    Journal: ORAL ONCOLOGY. 2023; Vol. 138, Issue , pp. -. DOI: 10.1016/j.oraloncology.2023.106331

  • A case of liposarcoma with osteolysis of the maxilla as the first symptom and review of the literature

    Author: Kuang, Yishen; Liang, Lizhong; Li, Xiangwei; Li, Tong

    Journal: ORAL ONCOLOGY. 2023; Vol. 139, Issue , pp. -. DOI: 10.1016/j.oraloncology.2023.106340

  • A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (>= 2 lines) anti-programmed death-1 monotherapy

    Author: Li, Su-Chen; Deng, Shen -Wen; Sun, Xue-Song; Lan, Kai-Qi; Guo, Chun-Yan; Lin, Da-Feng; Liu, Li-Ting; Liu, Sai-Lan; Mai, Hai-Qiang; Tang, Lin-Quan

    Journal: ORAL ONCOLOGY. 2023; Vol. 139, Issue , pp. -. DOI: 10.1016/j.oraloncology.2023.106336

  • The optimal number of examined lymph nodes for accurate nodal staging and favorable prognosis of oral tongue squamous cell carcinoma

    Author: Zhuge, Lingdun; Cai, Huizhu; Huang, Zehao; Wang, Shixu; Li, Zhengjiang

    Journal: ORAL ONCOLOGY. 2023; Vol. 140, Issue , pp. -. DOI: 10.1016/j.oraloncology.2023.106368

  • Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma

    Author: Zuo, Nan; Ma, Lin; Liu, Tianyang; Hu, Weitao; Luo, Yupeng; Meng, He; Ren, Qiushi; Deng, Yongqiang; Wei, Lanlan; Liu, Qi

    Journal: ORAL ONCOLOGY. 2023; Vol. 140, Issue , pp. -. DOI: 10.1016/j.oraloncology.2023.106367